Yahoo Web Search

Search results

1. Biodexa Pharmaceuticals Plc

   NasdaqCM: BDRX

   0.9802

   Add to watchlist

   Sign in to add to watchlist

   Sign In

   -0.0998 (-9.24%)

   At close:4:00 PM EDTWed. May 29, 2024

   0.9803 0.00 (0.01%)

   After hrs:5:38 PM EDTWed. May 29, 2024

   Nasdaq Real Time Price (USD) · Market closed

   Full chart

   • 1D
   • 5D
   • 1M
   • 6M
   • YTD
   • 1Y
   • MAX

   • Open	1.0200
     High	1.0400
     Low	0.9500

   • Mkt Cap	5.48M
     P/E (TTM)	N/A
     Div & Yield	N/A & N/A

   • Prev. Close	1.0800
     52 Wk. Low	0.6700
     52 Wk. High	9.7400

   More about BDRX

   Related stocks

   • MGOL
     MGO Global, Inc.
     MGOL
     0.6468
     -1.43%
   • SMFL
     Smart for Life, Inc.
     SMFL
     3.9100
     +16.72%
   • NKGN
     NKGen Biotech, Inc.
     NKGN
     1.6400
     +9.33%
   • CTNT
     Cheetah Net Supply Chain Service Inc.
     CTNT
     0.9600
     +9.05%
   • CMND
     Clearmind Medicine Inc.
     CMND
     1.1300
     -1.31%

   More on Yahoo Finance

2. Top Stories

   • bovnews

     Facts about Biodexa Pharmaceuticals Plc ADR (BDRX) Stock that you might not know

     Ladenburg Thalmann raised the price target for the Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX) stock to “a Buy”. The rating was released on February 08, 2024, according to finviz.

     1 day ago

   • 

     InvestorPlace on MSN.com

     Why Is Biodexa Pharmaceuticals (BDRX) Stock Up 78% Today?

     1 week ago

   • 

     MSN

     Biodexa Pharmaceuticals stock more than doubled on Tuesday: explore why

     1 week ago

   • Benzinga.com on MSN.com

     Biodexa Pharmaceuticals Stock Is Tumbling Wednesday: What's Going On?

     1 week ago

   • Seeking Alpha on MSN.com

     Biodexa rallies 80% on positive Phase 2 data for eRapa

     1 week ago

   View all

3. People also ask

   Is biodexa pharmaceuticals (BDRX) a good stock to buy today?

   • Another thing for traders to keep in mind is the penny stock status of Biodexa Pharmaceuticals. That comes from its prior closing price of $1.27 and a market capitalization of only about $5.569 million. With taking into account these factors, it’s possible that traders are enacting a short squeeze of BDRX shares today.

   Why Is Biodexa Pharmaceuticals (BDRX) Stock Up 78% Today?

   www.msn.com/en-us/money/markets/why-is-biodexa-pharmaceuticals-bdrx-stock-up-78-today/ar-BB1mMAao

   See all results for this question

   How many shares of BDRX stock changing hands?

   • This has more than 15.8 million shares of BDRX stock changing hands as of this writing. That’s well above the company’s daily average trading volume of about 3 million shares. Investors will note that the float for BDRX stock is sitting at 842.62 million shares.

   Why Is Biodexa Pharmaceuticals (BDRX) Stock Up 78% Today?

   www.msn.com/en-us/money/markets/why-is-biodexa-pharmaceuticals-bdrx-stock-up-78-today/ar-BB1mMAao

   See all results for this question

   How much money did BDRX lose in 2022?

   • Note that the said study was “partially supported by $20 million in grant from the Cancer Prevent and Research Institute” as per the press release on Tuesday. The Phase 2 trial saw participation from 30 adult patients in total. $BDRX ended last year with a net loss of £7.08 million – down from a £7.66 million loss in 2022.

   Biodexa Pharmaceuticals stock more than doubled on Tuesday: explore …

   www.msn.com/en-us/money/markets/biodexa-pharmaceuticals-stock-more-than-doubled-on-tuesday-explore-why/ar-BB1mNGfA

   See all results for this question

   When will biodexa present polyp burden data?

   • Biodexa plans to present the data at the Digestive Disease Week annual meeting, currently underway in Washington, D.C. The company plans to present polyp burden data at 12 months at the upcoming INSIGHT scientific conference, to be held in Barcelona from June 19 to 22.

   Biodexa rallies 80% on positive Phase 2 data for eRapa

   www.msn.com/en-us/money/markets/biodexa-rallies-80-on-positive-phase-2-data-for-erapa/ar-BB1mMNcS

   See all results for this question

4. finance.yahoo.com › quote › BDRXBiodexa Pharmaceuticals Plc (BDRX) Stock Price, News, Quote ...

   finance.yahoo.com › quote › BDRX

   • Cached

   Find the latest Biodexa Pharmaceuticals Plc (BDRX) stock quote, history, news and other vital information to help you with your stock trading and investing.

   • Profile

     See the company profile for Biodexa Pharmaceuticals Plc...

   • Historical Data

     Discover historical prices for BDRX stock on Yahoo Finance....

   • Chart

     Interactive Chart for Biodexa Pharmaceuticals Plc (BDRX),...

   • Analysis

     See Biodexa Pharmaceuticals Plc (BDRX) stock analyst...

   • Options

     View the basic BDRX option chain and compare options of...

5. finance.yahoo.com › quote › BDRXBiodexa Pharmaceuticals Plc (BDRX) Latest Stock News ...

   finance.yahoo.com › quote › BDRX

   • Cached

   May 22, 2024 · Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) CARDIFF, United Kingdom, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX), a clinical stage ...

6. www.google.com › finance › quoteBiodexa Pharmaceuticals PLC-ADR (BDRX) Price & News - Google

   www.google.com › finance › quote

   • Cached

   Get the latest Biodexa Pharmaceuticals PLC-ADR (BDRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

7. Videos

   • 

     1:08

     youtube.com

     BDRX Stock (Biodexa Pharmaceuticals stock analysis) BDRX STOCK PREDICTIONS BDRX STOCK Analysis BDRX

     May 21, 2024

     1 Views

   • 

     3:24

     youtube.com

     BDRX Stock - Biodexa Pharmaceuticals Plc Stock Breaking News Today | BDRX Stock Price Prediction

     May 22, 2024

     39 Views

   • 

     1:04

     youtube.com

     BDRX Stock (Biodexa Pharmaceuticals stock analysis) BDRX STOCK PREDICTIONS BDRX STOCK Analysis BDRX

     May 22, 2024

     1 Views

   View all

8. seekingalpha.com › news › 4094914-biodexa-sharesBiodexa shares rally 126% on rapamycin licensing deal

   seekingalpha.com › news › 4094914-biodexa-shares

   Apr 26, 2024 · Biodexa (BDRX) stock soared 126% Friday after the company announced an exclusive icensing deal to develop and commercialize eRapa, also known as rapamycin. Read more here.

9. markets.businessinsider.com › news › stocksBiodexa Enters Into Exclusive License to eRapa™, a Phase 3 ...

   markets.businessinsider.com › news › stocks

   • Cached

   Apr 26, 2024 · Biodexa Pharmaceuticals PLC (listed on NASDAQ: BDRX) is a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs.

10. www.marketwatch.com › investing › stockBDRX Stock Price | Biodexa Pharmaceuticals PLC ADR Stock ...

    www.marketwatch.com › investing › stock

    5 days ago · BDRX | A complete BDRX overview by MarketWatch. View the latest market news and prices, and trading information.

11. stockanalysis.com › stocks › bdrxBiodexa Pharmaceuticals Plc (BDRX) Stock Price, Quote & News ...

    stockanalysis.com › stocks › bdrx

    • Cached

    May 22, 2024 · Biodexa Announces Pricing of $5.2 Million Underwritten Public Offering. Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) CARDIFF, United Kingdom, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX), a clinical stage biopharmaceutical comp... 5 months ago - GlobeNewsWire.